(155 days)
Not Found
No
The device description and performance studies focus on optical and electrical properties, not data processing or algorithmic analysis. There is no mention of AI, ML, or image processing.
No.
The device is described as an "oral illumination and examination light designed for use by dental and medical professionals to be used as an adjunctive tool for fluorescence visualization of oral mucosal tissue." Its intended use is to "aid in visualization of oral mucosal abnormalities," not to treat them.
Yes
The device is described as an "adjunct to an oral examination to aid in visualization of oral mucosal abnormalities," indicating its role in diagnosis.
No
The device description explicitly states it is a "battery operated (CR123A), hand-held, oral illumination and examination light" and includes accessories like filtered eyewear, indicating it is a hardware device with physical components.
Based on the provided information, the OralID™ device is not an In Vitro Diagnostic (IVD).
Here's why:
- IVDs are used to examine specimens from the human body. The definition of an IVD involves testing samples like blood, urine, tissue, etc., outside of the body to obtain information about a person's health.
- OralID™ is used for direct visualization of tissue within the body. The device is a hand-held light used by a clinician to examine the oral mucosal tissue directly in the patient's mouth. It does not involve collecting a sample and testing it in a lab.
Therefore, OralID™ falls under the category of a medical device used for examination and visualization, not an IVD.
N/A
Intended Use / Indications for Use
OralID™ is intended to be used by a dentist or physician as an adjunct to an oral examination to aid in visualization of oral mucosal abnormalities, such as oral cancer and pre-cancer.
Product codes
NXV, HQY
Device Description
OrallD™ is a battery operated (CR123A), hand-held, oral illumination and examination light designed for use by dental and medical professionals to be used as an adjunctive tool for fluorescence visualization of oral mucosal tissue. OralID™ accessories include two pair of filtered eyewear for both the clinician and patient.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
oral mucosal tissue, oral cavity
Indicated Patient Age Range
Not Found
Intended User / Care Setting
dentist or physician
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
The following tests were conducted to evaluate the functionality and performance of the proposed OralID™ oral examination light:
- . Optical Safety
- Thermal Safety .
- . Optical Wavelength
- Optical Power Testing .
- Beam Quality
Oral IDTM conforms to electrical safety requirements and complies with the electromagnetic compatibility standards established by IEC 60601-1-2.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s)
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 872.6350 Ultraviolet detector.
(a)
Identification. An ultraviolet detector is a device intended to provide a source of ultraviolet light which is used to identify otherwise invisible material, such as dental plaque, present in or on teeth.(b)
Classification. Class II.
0
FORWARD SCIENCE LLC
2511 Wind Fall Ln Sugar Land, TX 77479 USA Ph: 855-696-7254
V. 510(k) SUMMARY
K123)69
MAR 1 3 2013
Submitted by:
Forward Science LLC 2511 Wind Fall Lane Sugar Land, TX 77479 Ph: 855-696-7254 Fax: 855-329-6725
| Contact Person: | Brian Pikkula, PhD |
|---|---|
| Date Prepared: | October 04, 2012 |
| Proprietary Name: | OralID™ |
| Common Name: | Oral Examination Light and Accessories |
| Classification: | Class II: 21 CFR § 872.6350 |
| Class I: (Exempt) 21 CFR § 886.5850 | |
| Classification Name: | Ultra-violet Detector - NXV (EAQ) |
| Photosensitive glasses - HQY (Exempt) | |
| Predicate Devices: | DentLight Oral Exan Light Kit (K101140) |
| DentLight Inc | |
| 1411 E. Campbell Rd, Suite 500 | |
| Richardson, TX 75081 | |
| VELscope Vx (K102083) | |
| LED Medical Diagnostics | |
| 235 - 5589 Byrne Road | |
| Burnaby, BC, Canada, V5J 3J1 |
Device Description:
OrallD™ is a battery operated (CR123A), hand-held, oral illumination and examination light designed for use by dental and medical professionals to be used as an adjunctive tool for fluorescence visualization of oral mucosal tissue. OralID™ accessories include two pair of filtered eyewear for both the clinician and patient.
Intended Use:
OralID™ is intended to be used by a dentist or physician as an adjunct to an oral examination to aid in visualization of oral mucosal abnormalities, such as oral cancer and pre-cancer.
1
FORWARD SCIENCE LLC
Technological Characteristics:
OralID™ uses "CR123A" batteries to operate one high intensity LED to emit a visible blue light to aid in visualization of oral mucosal abnormalities, such as oral cancer. While using the filtered glasses and OralID™ oral examination light, healthy tissue fluoresces while abnormal tissue appears dark due to lack of fluorescence.
Substantial Equivalence
OrallD™ has the same intended use and technical characteristics as the predicate devices (K 101140 and K 102083); each uses fluorescence as the primary mode to aid in visualization of tissue for determining oral tissue abnormalities.
Predicate K101140 uses rechargeable batteries to power high-intensity LEDs that produces a violet light and views fluorescence through filtered loupes.
Predicate K102083 uses rechargeable lithium ion batteries to power high-intensity LEDs that produce blue light and views fluorescence through a hand piece with a filtered lens.
OralID™ uses "CR123A" batteries to power a high-intensity LED that produces blue light as illumination for excitation for tissue fluorescence viewed through filtered eyewear.
The only technological difference from the predicate devices is the power source. While both predicate devices use rechargeable batteries, OralID™ uses primary CR123A batteries to power the device, which decreases the electrical safety risk of the recharging process.
The operational principles of the proposed and predicate devices are identical with the primary mode to aid in visualization of tissue through fluorescence. Each of these devices is powered by batteries and uses LED technology to illuminate the oral cavity view the tissue fluorescence through a filtered lens.
The design, materials, method of operation, and labeling are substantially equivalent.
OralID™ is substantially equivalent to the cleared predicate devices.
Performance Testing and Compliance
The following tests were conducted to evaluate the functionality and performance of the proposed OralID™ oral examination light:
- . Optical Safety
- Thermal Safety .
- . Optical Wavelength
- Optical Power Testing .
- Beam Quality �
Oral IDTM conforms to electrical safety requirements and complies with the electromagnetic compatibility standards established by IEC 60601-1-2.
2
Image /page/2/Picture/1 description: The image shows the logo for the Department of Health & Human Services - USA. The logo features a stylized eagle with three stripes emanating from its head, representing the department's mission to protect the health of all Americans and provide essential human services. The text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" is arranged in a circular fashion around the eagle.
Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002
March 13, 2013
Dr. Brian Pikkula President & CTO Forward Science LLC 2511 Wind Fall Lane SUGAR LAND TX 77479
Re: K123169
Trade/Device Name: OralID™M Regulation Number: 21 CFR 872.6350 Regulation Name: Ultraviolet Detector -Regulatory Class: II Product Code: NXV Dated: February 6, 2013 Received: February 11, 2013
Dear Dr. Pikkula:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA), You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you; however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
3
Page 2 - Dr. Pikkula
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please go to http://www.fda.gov/AboutFDA/CentersOffices/CDRH/CDRHOffices/ucm115809.htm for the Center for Devices and Radiological Health's (CDRH's) Office of Compliance. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/Resourcesfor You/Industry/default.htm.
Sincerely yours,
Image /page/3/Picture/6 description: The image shows the text "Kwame O. Ulmer for". The text is written in a simple, sans-serif font. The letters "FDA" are in the middle of the name, with the letters stylized with lines.
Anthony D. Watson, B.S., M.S., M.B.A. Director Division of Anesthesiology, General Hospital, Respiratory, Infection Control and Dental Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
4
FORWARD SCIENCE LLC
IV. Indications for Use
Applicant:
Forward Science LLC 2511 Wind Fall Lane Sugar Land, TX 77479 Ph: 855-696-7254 Fax: 855-329-6725 ·
510(k) Number (if Known): K123169
Device Name:
OralIDTM
Indications For Use:
OralID™ is intended to be used by a dentist or physician as an adjunct to an oral examination to aid in visualization of oral mucosal abnormalities, such as oral cancer and pre-cancer.
Prescription Use X (Per 21 CFR 801 Subpart D)
AND/OR
Over-the-Counter (Per 21 CFR 801 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
Mary S. Runner -S 2013:03.13 ANA BA 13:22:37-04'00'
(Division Sign-Off) Division of Anestheslology, General Hospital Infection Control, Dental Devices
510(k) Number:
. . .
Same Comments of Children : . . .